Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-011331

SVP, Chief Accounting Officer sold 1,829 shares at $7.45 ($13,631)

  • SVP, Chief Accounting Officer acquired 25,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sabatini Brent SVP, Chief Accounting Officer 2026-02-22 Grant or award 10b5-1 +25,000 72,872 D
Sabatini Brent SVP, Chief Accounting Officer 2026-02-23 Sale 10b5-1 −1,829 $7.45 $13,631 71,043 D
Derivatives
Sabatini Brent SVP, Chief Accounting Officer 2026-02-22 Grant or award · Stock Option (Right to Buy) 10b5-1 +50,000 50,000 D
Open-market sales · 1,829 sh · avg $7.45 · $13,631
Loading xslF345X05/wk-form4_1771978411.xml…